|
Market Closed -
OTC Markets
19:18:04 03/12/2025 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 5 years | 0 |  | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 02/08/2012 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 20/01/2010 |
Steven Byle
BRD | Director/Board Member | 58 | 09/11/2009 |
Roger Fidler
BRD | Director/Board Member | 75 | 30/12/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,032B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 614B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 471B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 350B | |
| +0.37% | +0.14% | +21.29% | +40.99% | 337B | |
| +0.44% | -3.09% | +10.76% | +32.59% | 268B | |
| -0.16% | -3.78% | -6.03% | +9.29% | 246B | |
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| Average | +0.15% | -3.05% | +26.44% | +56.59% | 371.48B | |
| Weighted average by Cap. | -0.07% | -3.18% | +29.54% | +67.00% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
